BAFNAPH2020-01-012020-03-31in-bse-fin:OneOperatingExpenses01Member BAFNAPH2020-01-012020-03-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares BAFNAPH 2019-04-01 2020-03-31 2020-06-13 INR Lakhs Yearly Single segment Pharmaceutical Formulations 2020-01-01 2020-03-31 Audited Consolidated 131328000.00 -6706000.00 124622000.00 64074000.00 0.00 -17228000.00 30826000.00 252000.00 5249000.00 11213000.00 94386000.00 30236000.00 -8413000.00 21823000.00 0.00 15778000.00 15778000.00 0.00 6045000.00 0.00 0.00 0.00 -2869000.00 3176000.00 0.00 3176000.00 0.00 0.00 0.00 0.00 23650000.00 10 0.20 0.20 0.00 0.00 0.20 0.20 0.00 0.00 0.00 Single segment 2019-04-01 2020-03-31 Audited Consolidated 424724000.00 2553000.00 427277000.00 302425000.00 190000.00 -32378000.00 102516000.00 955000.00 32666000.00 39738000.00 446112000.00 -18835000.00 -225591000.00 -244426000.00 0.00 0.00 0.00 0.00 -244426000.00 0.00 0.00 0.00 -2869000.00 -247295000.00 0.00 -247295000.00 0.00 0.00 0.00 0.00 23656000.00 10 511147000.00 -15.52 -15.52 0.00 0.00 -15.52 -15.52 0.00 0.00 0.00 Other Expenses 11213000.00 Other Expenses 39738000.00